(19)

(11)

EP 3 478 593 A2

(12)

(88) Date of publication A3: 08.02.2018 (43) Date of publication: 08.05.2019 Bulletin 2019/19 (21) Application number: 17819428.8 (22) Date of filing: 29.06.2017

(51) International Patent Classification (IPC):  B65D 17/00(2006.01) B65D 77/22(2006.01) B65D 73/00(2006.01) (86) International application number: PCT/IB2017/000960 (87) International publication number: WO 2018/002721 (04.01.2018 Gazette 2018/01)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: MA MD (30) Priority: 29.06.2016 US 201662356146 P 31.08.2016 US 201662381932 P (71) Applicant: Glasshouse Pharmaceuticals Limited Canada Mississauga, ON L5N 6L6 (CA)	(72) Inventors: RUTTER, Bryce, G. St.Louis, MO 63108 (US) SAWICKI, Craig St. Louis, MO 63141 (US) (74) Representative: Thorniley, Peter et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD London EC1A 4HD (GB)